A nurse working in the neonatal intensive care unit is caring for a premature infant receiving colfosceril malmitate. The nurse understands that this agent is used as a:
a. bronchodilator. c. lung surfactant.
b. mucolytic. d. sympathomimetic.
ANS: C
Feedback
A Incorrect: This agent is not a bronchodilator.
B Incorrect: This agent is not a mucolytic.
C Correct: Lack of surfactant is the most common cause of neonatal respiratory distress syndrome in premature infants. Colfosceril malmitate is a lung surfactant.
D Incorrect: This agent is not a sympathomimetic.
You might also like to view...
Why is it important for new graduates to purchase their own malpractice insurance rather than depend on an institutional policy?
a. A private policy will not cover them unless they are on their primary job. b. A private policy will carry personal liability coverage. c. A private policy will protect them against all lawsuits. d. A private policy will protect them from losing their license.
When assessing a patient's skin, which of the following characteristics of skin should the nurse keep in mind?
A) The epidermis is highly vascular. B) Lymphatic vessels drain the epidermis. C) Blood vessels in the dermis nourish the epidermis. D) Hair follicles originate in the dermis.
Hypercalcemia in the myocardium results in:
A) increased contractility. B) increased irritability. C) decreased contractility. D) decreased irritability.
The patient has lung cancer and voices concerns about his cancer treatment. He wants to know how chemotherapy will affect his sexuality. What is the nurse's best reply?
a. "Chemotherapy will work in the lungs and should have no effect on your sexuality." b. "That is something that you should ask your doctor. He can direct you." c. "Sexual changes are common with cancer therapy. Let me get someone who can answer your questions." d. "How cancer treatment affects sexuality depends on how active you are and your age."